ChronoScale Holdings Corporation
18.18USD
-2.8800 (-13.68%)
32 filings from 16 insiders · 103 buy / 34 sell over 6m
Officers and directors of CHRN, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| WONG JEROMEChief Financial Officer | Grant | 300.0k | — | — | Aug 14, 2026 |
| JEGANNATHAN RAJASEKARChief Technology Officer | Grant | 1.40M | — | — | Jul 22, 2026 |
| CHEN YING CENLYChief Executive Officer | Grant | 2.80M | — | — | Jul 13, 2026 |
| SCHAAP ANDREW CORDELLDirector | Grant | 200.0k | — | — | Jun 29, 2026 |
| BENSON ELLA GDirector | Grant | 200.0k | — | — | May 14, 2026 |
| WONG JEROMEChief Financial Officer | Grant | 40.0k | — | — | May 14, 2026 |
| CLANCY WILLIAM MDirector | Grant | 200.0k | — | — | May 14, 2026 |
| MILLER DOUGLAS SDirector | Grant | 200.0k | — | — | May 14, 2026 |
| NOTTENBURG RICHARD NDirector | Grant | 200.0k | — | — | May 14, 2026 |
| CUMMINS WESLEYDirector | Grant | 200.0k | — | — | May 14, 2026 |
| DAVIS SCOTT GERALDDirector | Grant | 109.4k | — | — | May 14, 2026 |
| JONES JASON CChief Operating Officer | Buyindirect | 1.3k | $11.85 | $16k | Mar 16, 2026 |
| WONG JEROMEChief Financial Officer | Buyindirect | 1.3k | $11.85 | $16k | Mar 16, 2026 |
| ASHER DANIELBeneficial Owner of more than 10% of a Class of Security | Buyindirect | 1.2k | $9.60 | $12k | Feb 19, 2026 |
| ASHER DANIELBeneficial Owner of more than 10% of a Class of Security | Buyindirect | 15.5k | $12.30 | $191k | Feb 19, 2026 |
| ASHER DANIELBeneficial Owner of more than 10% of a Class of Security | Buyindirect | 102.0k | $8.96 | $970k | Feb 13, 2026 |
| JONES JASON CChief Operating Officer | Sell | 1.3k | $9.25 | $12k | Jan 6, 2026 |
| JONES JASON CChief Operating Officer | Sell | 270 | $4.70 | $1k | Dec 9, 2025 |
| WONG JEROMEChief Financial Officer | Sell | 1.2k | $4.70 | $6k | Dec 9, 2025 |
| DAVIS SCOTT GERALDChief Executive Officer | Sell | 23.3k | $4.80 | $112k | Nov 10, 2025 |
No analyst notes on CHRN yet.